-
Vibrant Occasions to Serve Exclusive Wonka-Inspired Menu at ALS In Wonderland Foundation's 10th Annual ALS Soiree'
19 Apr 2024 20:54 GMT
… during their challenging journey.
ALS, or amyotrophic lateral sclerosis, is a progressive … for ALS, but ongoing research aims to develop effective treatments … individuals and families affected by amyotrophic lateral sclerosis (ALS) in Arkansas. Attendees …
-
Synapticure partners with ALS Association to expand telehealth access
18 Apr 2024 17:35 GMT
… care at ALS Certified Treatment Centers of Excellence and Recognized Treatment Centers.
… neurodegenerative diseases. It provides treatment for conditions such as Alzheimer … geography. In partnership with the ALS Association, harnessing our combined …
-
Many Cancer Drugs Granted Accelerated Approval May Not Offer Clinical Benefit
18 Apr 2024 15:44 GMT
… of HIV, the FDA approves medications that suppress viral load and … indication or for earlier treatment. “Most cancer drugs granted accelerated approval did … was granted accelerated approval for amyotrophic lateral sclerosis based on Phase II trial …
-
Coya Therapeutics to Participate in the 3rd Annual ALS Drug Development Summit
18 Apr 2024 14:53 GMT
… in the 3rd Annual ALS Drug Development Summit … on Top of Existing ALS Treatments” in Workshop B.
… Immunotherapy in the Treatment of ALS by Treg Activity … being developed for the treatment of Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Parkinson …
-
Coya Therapeutics to Participate in the 3rd Annual ALS Drug Development Summit
18 Apr 2024 12:26 GMT
… in the 3rd Annual ALS Drug Development Summit … on Top of Existing ALS Treatments” in Workshop B.
… Immunotherapy in the Treatment of ALS by Treg Activity … being developed for the treatment of Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Parkinson …
-
Corcept Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis (ALS)
15 Apr 2024 12:00 GMT
… the discovery and development of medications to treat severe endocrinologic, … modulator dazucorilant in patients with amyotrophic lateral sclerosis (ALS).
DAZALS enrolled 249 patients, … States and Canada. “Better treatments for ALS are urgently needed,” said …
-
Triangle ALS walk aims to promote awareness and research for rare disease
17 Apr 2024 22:16 GMT
… Mall for the annual Walk ALS event.
The event promotes … his experience at local Triangle ALS events and even lobbied … , the distinguished professor of ALS at Duke University said when … they also uncovered new drug treatments that could provide a breakthrough …
-
Amylyx and ALS, Continued ADC Excitement, Dire Drug Shortages
17 Apr 2024 14:45 GMT
… failed Phase III trial in amyotrophic lateral sclerosis. Analysts and insiders spoke with … possible regulatory precedent for other drugs approved based on a single …
-
Amylyx Sheds More Light on Relyvrio’s Late-Stage Trial Failure in ALS
17 Apr 2024 13:57 GMT
… that measures the severity of amyotrophic lateral sclerosis (ALS) including the progression of … from baseline. The resulting treatment effect was 0.343, … points in the Amyotrophic Lateral Sclerosis Assessment Questionnaire. Both treatment effects fell short …
-
What to know about bulbar onset ALS
17 Apr 2024 08:57 GMT
… is currently no cure for ALS. Treatments cannot yet reverse motor neuron … improve quality of life.
Medications
Treatment for bulbar onset ALS may include:
Riluzole … cause.
Bulbar onset amyotrophic lateral sclerosis (ALS) is a type of ALS that affects motor …